pharma · EBV-induced Lymphomas · Coronary Artery Disease
Evidence Based Cataract
Evidence Based Cataract Study Group
Evidence Based Cataract trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
THOUSAND OAKS, CA, CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- THOUSAND OAKS, CA, CN
- Programs
- 10
- Drugs
- 8
- Patents
- 10
Evidence Based Cataract clinical trials
Registry index of 10 ClinicalTrials.gov studies linked to Evidence Based Cataract programs — each row shows trial ID, program name, phase, status, and indication.
Evidence Based Cataract trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Evidence Based Cataract.
-
Clopidogrel — Approved
Clinical update -
cyclophosphamide — Phase 1
Clinical update -
WT1-sensitized T cells — Phase 1
Clinical update -
Tabelecleucel — Phase 2
Clinical update -
EBV-specific T cells (EBV-CTLs) — Phase 2
Clinical update -
ATA3219 — Phase 1
Clinical update -
ATA188 — Phase 2
Clinical update -
CMV-pp65 CTLs — Phase 2
Clinical update